Loading...
XHKG
1497
Market cap398mUSD
Dec 05, Last price  
6.80HKD
1D
-1.45%
1Q
-7.48%
IPO
-24.44%
Name

Xiamen Yan Palace Bird's Nest Industry Co Ltd

Chart & Performance

D1W1MN
XHKG:1497 chart
P/E
18.03
P/S
1.37
EPS
0.34
Div Yield, %
3.47%
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
2.05b
+4.37%
1,462,101,4921,816,249,2892,011,715,3241,964,237,0002,050,000,000
Net income
156m
-22.33%
122,017,000167,353,000191,840,000201,218,000156,295,000
CFO
257m
+108.66%
56,835,286257,515,013355,217,425123,351,000257,383,000
Dividend
May 23, 20240.23626 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Xiamen Yan Palace Bird's Nest Industry Co., Ltd. engages in the development, production, and marketing of edible bird's nest (EBN) products in the People's Republic of China. It operates through five segments: Direct Sales to Online Customers, Direct Sales to Offline Customers, Sales to Offline Distributors, Direct Sales to E-commerce Platform, and Sales to Online Distributors. The company offers One Nest, a bowl-shape-canned EBN product series for the lifestyle of beauty and wellness; Freshly Stewed Bird's Nest, a bottle-canned EBN product series; Crystal Sugar Bird's Nest, a bottle-canned crystal sugar flavored EBN product series; and dried EBN products. It also provides EBN+ products under the One Nest — Vitality, Crystal Sugar Bird's Nest with Ginseng, and Little Blue Bottle names; and +EBN products, including food products, such as EBN porridge, EBN zongzi, and various EBN beverages, as well as a range of EBN skincare products. The company offers its products through stores, as well as online. Xiamen Yan Palace Bird's Nest Industry Co., Ltd. was formerly known as Xiamen Yan Palace Bioengineering Co., Ltd. and changed its name to Xiamen Yan Palace Bird's Nest Industry Co., Ltd. in November 2023. The company was founded in 1997 and is headquartered in Xiamen, the People's Republic of China.
IPO date
Dec 12, 2023
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT